GB202112635D0 - Treatment regimen - Google Patents

Treatment regimen

Info

Publication number
GB202112635D0
GB202112635D0 GBGB2112635.4A GB202112635A GB202112635D0 GB 202112635 D0 GB202112635 D0 GB 202112635D0 GB 202112635 A GB202112635 A GB 202112635A GB 202112635 D0 GB202112635 D0 GB 202112635D0
Authority
GB
United Kingdom
Prior art keywords
treatment regimen
regimen
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2112635.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diurnal Ltd
Original Assignee
Diurnal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Ltd filed Critical Diurnal Ltd
Priority to GBGB2112635.4A priority Critical patent/GB202112635D0/en
Publication of GB202112635D0 publication Critical patent/GB202112635D0/en
Ceased legal-status Critical Current

Links

GBGB2112635.4A 2021-09-06 2021-09-06 Treatment regimen Ceased GB202112635D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2112635.4A GB202112635D0 (en) 2021-09-06 2021-09-06 Treatment regimen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2112635.4A GB202112635D0 (en) 2021-09-06 2021-09-06 Treatment regimen

Publications (1)

Publication Number Publication Date
GB202112635D0 true GB202112635D0 (en) 2021-10-20

Family

ID=78076759

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2112635.4A Ceased GB202112635D0 (en) 2021-09-06 2021-09-06 Treatment regimen

Country Status (1)

Country Link
GB (1) GB202112635D0 (en)

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BERR CMDI DALMAZI GOSSWALD ARITZEL KBIDLINGMAIER MGEYER LLTREITL MHALLFELDT KRACHINGER WREISCH N: "Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology", J CLIN ENDOCRINOL METAB, vol. 100, 2015, pages 1300 - 1308
BORNSTEIN SRALLOLIO BARLT WBARTHEL ADON-WAUCHOPE AHAMMER GDHUSEBYE ESMERKE DPMURAD MHSTRATAKIS CA: "Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline", J CLIN ENDOCRINOL METAB, vol. 101, 2016, pages 364 - 389
BROERSEN LHPEREIRA AMJORGENSEN JODEKKERS OM: "Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis", J CLIN ENDOCRINOL METAB, vol. 100, 2015, pages 2171 - 2180
BURMESTER GRBUTTGEREIT FBERNASCONI CALVARO-GRACIA JMCASTRO NDOUGADOS MGABAY CVAN LAAR JMNEBESKY JMPETHOE-SCHRAMM A: "Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial", LANCET, vol. 396, 2020, pages 267 - 276, XP086226070, DOI: 10.1016/S0140-6736(20)30636-X
BUTTGEREIT FDOERING GSCHAEFFLER AWITTE SSIERAKOWSKI SGROMNICA-LHLE EJEKA SKRUEGER KSZECHINSKI JALTEN R: "Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis", ANN RHEUM DIS, vol. 69, 2010, pages 1275 - 1280
GRABER ALNEY RLNICHOLSON WEISLAND DPLIDDLE GW: "Natural History of Pituitary-Adrenal Recovery Following Long-Term Suppression with Corticosteroids", J CLIN ENDOCRINOL METAB, vol. 25, 1965, pages 11 - 16
JOSEPH RMHUNTER ALRAY DWDIXON WG: "Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review", SEMIN ARTHRITIS RHEUM, vol. 46, 2016, pages 133 - 141, XP029666365, DOI: 10.1016/j.semarthrit.2016.03.001
SIMPSON HTOMLINSON JWASS JDEAN JARLT W: "Guidance for the prevention and emergency management of adult patients with adrenal insufficiency", CLIN MED (LOND, vol. 20, 2020, pages 371 - 378
WALLACE BIWALLACE DMWALJEE AKCLAUW DJ: "Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking", ANN RHEUM DIS, vol. 78, 2019, pages 1733 - 1734
WHITAKER MJDEBONO MHUATAN HMERKE DPARLT WROSS RJ: "An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure", CLIN ENDOCRINOL (OXF, vol. 80, 2014, pages 554 - 561, XP055129260, DOI: 10.1111/cen.12316

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202116743D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202112635D0 (en) Treatment regimen
GB202019215D0 (en) Treatment regimen
GB202017853D0 (en) Treatment regimen
GB202008478D0 (en) Treatment regimen
GB202001514D0 (en) Treatment regimen
GB202212963D0 (en) Treatment regimen
GB202117511D0 (en) Treatment regimens
GB202114373D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment
GB202102410D0 (en) Treatment
GB202102366D0 (en) Treatment
GB202102373D0 (en) Treatment
GB202102369D0 (en) Treatment
GB202101875D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)